83 related articles for article (PubMed ID: 9242440)
21. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities.
Matsumura Y; Sugiyama M; Matsumura S; Hayle AJ; Robinson P; Smith JC; Tarin D
J Pathol; 1995 Sep; 177(1):11-20. PubMed ID: 7472774
[TBL] [Abstract][Full Text] [Related]
22. The splice-pattern of CD44 is altered in chronic pancreatitis exhibiting dysplastic changes.
Gansauge F; Gansauge S; Schlosser W; Schmid R; Adler G; Beger HG
Eur J Med Res; 1998 Sep; 3(9):419-26. PubMed ID: 9737888
[TBL] [Abstract][Full Text] [Related]
23. Expression of the Cell Adhesion Molecule CD44 in Human Lung Tumors and Cell Lines.
Resnick NM; Clarke MR; Siegfried JM; Landreneau R; Asman DC; Ge L; Kierstead LS; Dougherty GD; Cooper DL
Mol Diagn; 1998 Jun; 3(2):93-103. PubMed ID: 10029660
[TBL] [Abstract][Full Text] [Related]
24. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
[TBL] [Abstract][Full Text] [Related]
25. CD44 variant exon 6 expressions in colon cancer assessed by quantitative analysis using real time reverse transcriptase-polymerase chain reaction.
Yamada Y; Itano N; Narimatsu H; Kudo T; Hirohashi S; Ochiai A; Tohnai I; Ueda M; Kimata K
Oncol Rep; 2003; 10(6):1919-24. PubMed ID: 14534719
[TBL] [Abstract][Full Text] [Related]
26. Tissue-specific and growth-regulated expression of CD44 variable exon determinants in the mouse.
Yamashita Y; Hirano H; Hodes RJ
Cell Immunol; 1997 Feb; 176(1):22-33. PubMed ID: 9070314
[TBL] [Abstract][Full Text] [Related]
27. Expression patterns of CD44 adhesion molecule in testicular germ cell tumors and normal testes.
Miyake H; Hara I; Yamanaka K; Gohji K; Arakawa S; Kamidono S
Am J Pathol; 1998 May; 152(5):1157-60. PubMed ID: 9588883
[TBL] [Abstract][Full Text] [Related]
28. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.
Woodman AC; Sugiyama M; Yoshida K; Sugino T; Borgya A; Goodison S; Matsumura Y; Tarin D
Am J Pathol; 1996 Nov; 149(5):1519-30. PubMed ID: 8909242
[TBL] [Abstract][Full Text] [Related]
29. Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching.
Keller KE; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1164-72. PubMed ID: 17325160
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronidase can modulate expression of CD44.
Stern R; Shuster S; Wiley TS; Formby B
Exp Cell Res; 2001 May; 266(1):167-76. PubMed ID: 11339835
[TBL] [Abstract][Full Text] [Related]
31. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma.
Kim YS; Chi SG; Kim YW; Park YK; Yoon C
J Korean Med Sci; 1997 Dec; 12(6):505-13. PubMed ID: 9443088
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of Immature Intron-containing CD44 Gene Transcripts in Breast Cancer Tissues.
Bolodeoku J; Yoshida K; Sugino T; Goodison S; Tarin D
Mol Diagn; 1996 Sep; 1(3):175-181. PubMed ID: 10462558
[TBL] [Abstract][Full Text] [Related]
34. Effect of changes in the CD44 gene on tumour cell invasion in gliomas.
Bouterfa H; Janka M; Meese E; Kerkau S; Roosen K; Tonn JC
Neuropathol Appl Neurobiol; 1997 Oct; 23(5):373-9. PubMed ID: 9364462
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel splice variants of the human CD44 gene.
Vela E; Roca X; Isamat M
Biochem Biophys Res Commun; 2006 Apr; 343(1):167-70. PubMed ID: 16530165
[TBL] [Abstract][Full Text] [Related]
36. Intron 9 retention in gene transcripts suggests involvement of CD44 in the tumorigenesis of ovarian cancer.
Stickeler E; Möbus VJ; Kieback DG; Kohlberger P; Runnebaum IB; Kreienberg R
Anticancer Res; 1997; 17(6D):4395-8. PubMed ID: 9494539
[TBL] [Abstract][Full Text] [Related]
37. Splice variant expression of CD44 in patients with breast and ovarian cancer.
Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
[TBL] [Abstract][Full Text] [Related]
38. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
[TBL] [Abstract][Full Text] [Related]
39. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints.
Wibulswas A; Croft D; Pitsillides AA; Bacarese-Hamilton I; McIntyre P; Genot E; Kramer IM
Arthritis Rheum; 2002 Aug; 46(8):2059-64. PubMed ID: 12209509
[TBL] [Abstract][Full Text] [Related]
40. Exon 14-skipping of the adenomatous polyposis coli gene in purified epithelial cells of colonic mucosa and tumors.
Sulekova Z; Reymond M; Köckerling F; Hohenberger W; Ballhausen WG
Anticancer Res; 1999; 19(1A):601-4. PubMed ID: 10226605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
